CSIMarket
 


Nuvation Bio Inc   (NUVB)
Other Ticker:  
 
 

NUVB's Net Cash Flow Growth by Quarter and Year

Nuvation Bio Inc 's Net Cash Flow results by quarter and year




NUVB Net Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -212.21 0.00 0.00
III Quarter September 36.37 -104.90 0.00 0.00
II Quarter June -3.89 -189.37 0.00 0.00
I Quarter March -26.22 609.15 0.00 0.00
FY   6.26 102.67 0.00 0.00



NUVB Net Cash Flow third quarter 2022 Y/Y Growth Comment
Nuvation Bio Inc in the third quarter 2022 achieved Net Cash Flow of $ 36.37 millions compare to net cash outflow recorded in same quarter a year ago.

According to the results reported in the third quarter 2022, Nuvation Bio Inc achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Nuvation Bio Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 0 in the third quarter 2022.




NUVB Net Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Nuvation Bio Inc 's third quarter 2022 Net Cash Flow $ 36.37 millions NUVB's Income Statement
Nuvation Bio Inc 's third quarter 2021 Net Cash Flow $ -104.90 millions Quarterly NUVB's Income Statement
New: More NUVB's historic Net Cash Flow Growth >>


NUVB Net Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Nuvation Bio Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NUVB's III. Quarter Q/Q Net Cash Flow Comment
Improvement III. Quarter 2022where Nuvation Bio Inc published Net Cash Flow of $ 36.37 millions may be beginning of improved business climet.Nuvation Bio Inc announced in the III. Quarter 2022 Net Cash Flow of $ 36.37 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Nuvation Bio Inc achieved highest sequential Net Cash Flow growth. While Nuvation Bio Inc 's Net Cash Flow growth quarter on quarter, overall rank is 0.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NUVB's III. Quarter Q/Q Net Cash Flow Comment
This turnaround III. Quarter 2022where Nuvation Bio Inc posted Net Cash Flow of $ 36.37 millions could be beginning of better results.Nuvation Bio Inc announced in the III. Quarter 2022 Net Cash Flow of $ 36.37 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Nuvation Bio Inc achieved highest sequential Net Cash Flow growth. While Nuvation Bio Inc 's Net Cash Flow growth quarter on quarter, overall rank is 0.


Nuvation Bio Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Net Cash Flow 12 Months Ending $ -205.94 $ -347.21 $ -532.70 $ 102.67 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - -51.83 % -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
Nuvation Bio Inc realized trailing twelve months net cash outflow of $ -206 millions, in the Sep 30 2022, compare to Net Cash Flow of $ 213 millions a year ago.

Nuvation Bio Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
Nuvation Bio Inc realized trailing twelve months net cash outflow of $ -206 millions, in the Sep 30 2022, compare to Net Cash Flow of $ 213 millions a year ago.

Nuvation Bio Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
NUVB's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for NUVB's Competitors
Net Cash Flow Growth for Nuvation Bio Inc 's Suppliers
Net Cash Flow Growth for NUVB's Customers

You may also want to know
NUVB's Annual Growth Rates NUVB's Profitability Ratios NUVB's Asset Turnover Ratio NUVB's Dividend Growth
NUVB's Roe NUVB's Valuation Ratios NUVB's Financial Strength Ratios NUVB's Dividend Payout Ratio
NUVB's Roa NUVB's Inventory Turnover Ratio NUVB's Growth Rates NUVB's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2022
Horizon Therapeutics Public Limited Company-7.13%$ -7.126 millions
Abbvie Inc -8.94%$ -8.938 millions
Reflect Scientific Inc -10.82%$ -10.823 millions
Integra Lifesciences Holdings Corp-11.03%$ -11.030 millions
Ngm Biopharmaceuticals Inc -12.70%$ -12.705 millions
Monte Rosa Therapeutics Inc -13.05%$ -13.054 millions
Ironwood Pharmaceuticals inc -13.90%$ -13.897 millions
Harmony Biosciences Holdings inc -17.35%$ -17.350 millions
Amgen Inc -19.48%$ -19.479 millions
Relmada Therapeutics Inc -22.37%$ -22.367 millions
Teleflex Incorporated-25.34%$ -25.336 millions
Semler Scientific inc -25.80%$ -25.799 millions
Kiora Pharmaceuticals inc -27.15%$ -27.153 millions
American Bio Medica Corporation-27.27%$ -27.273 millions
Axim Biotechnologies Inc -27.61%$ -27.615 millions
Tcr2 Therapeutics Inc -28.60%$ -28.597 millions
Imara inc -30.72%$ -30.725 millions
Utah Medical Products Inc-31.73%$ -31.734 millions
Tenaya Therapeutics Inc -32.90%$ -32.897 millions
Tandem Diabetes Care Inc -36.07%$ -36.073 millions
Cadre Holdings inc -39.62%$ -39.623 millions
Bionexus Gene Lab Corp -43.99%$ -43.986 millions
Vaxxinity Inc -46.28%$ -46.279 millions
Plus Therapeutics Inc -47.17%$ -47.172 millions
Seres Therapeutics Inc -48.80%$ -48.798 millions
Fate Therapeutics Inc -48.94%$ -48.943 millions
Myovant Sciences Ltd -51.54%$ -51.540 millions
Imaging Diagnostic Systems Inc -51.83%$ -51.826 millions
Vbi Vaccines Inc-53.50%$ -53.500 millions
United Health Products Inc -56.21%$ -56.211 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CRK's Profile

Stock Price

CRK's Financials

Business Description

Fundamentals

Charts & Quotes

CRK's News

Suppliers

CRK's Competitors

Customers & Markets

Economic Indicators

CRK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071